Legacy Wealth Partners (California)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-9,627
Closed -$537K 98
2020
Q1
$537K Sell
9,627
-199
-2% -$12.2K 0.5% 36
2019
Q4
$645K Buy
+9,826
New +$563K 0.47% 47

Other funds holding BMY

Legacy Wealth Partners (California)'s BMY Position: Q2 2020 in Review

Legacy Wealth Partners (California) sold out of Bristol-Myers Squibb (BMY) in Q2 2020, closing a stake of 9,627 shares — an estimated $537K sold.

Legacy Wealth Partners (California) first reported a position in BMY in Q4 2019 and held it in 2 quarters. The position peaked at $645K in Q4 2019. 2,189 funds tracked by Wall St. Rank hold BMY as of Q2 2020.

  • Legacy Wealth Partners (California) reported no remaining Bristol-Myers Squibb position as of Q2 2020 after selling out during the quarter.
  • Legacy Wealth Partners (California) sold 9,627 Bristol-Myers Squibb shares in Q2 2020, an estimated $537K.
  • Legacy Wealth Partners (California) first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 2 quarters.
  • Legacy Wealth Partners (California)'s Bristol-Myers Squibb position peaked at $645K in Q4 2019.
  • 2,189 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.

Based on Legacy Wealth Partners (California)'s 13F filing for Q2 2020, filed 5 Aug 2020.